Exhibiting at Japan Healthcare Venture Summit (JHVS) 2022
We have been selected to exhibit at the “Japan Healthcare Venture Summit (JHVS)” organized by the Ministry of Health, Labour and Welfare. Next month, we will have a booth at Pacifico Yokohama for three days starting October 12.
This event is held concurrently with three other exhibitions: “BioJapan” (since 1986), one of the world’s longest-running biotechnology exhibitions; “Regenerative Medicine JAPAN,” which aims to accelerate research and development and industrialization in the regenerative medicine field including iPS cells; and “healthTECH JAPAN,” which focuses on creating new value through the fusion of digital technology and life sciences.
We would be delighted if you could visit our booth when attending.
Event Details
- Name: Japan Healthcare Venture Summit (JHVS) 2022
- Dates: October 12-14, 2022
- Venue: Pacifico Yokohama
- Booth Number: V-48
- Organizer: Ministry of Health, Labour and Welfare
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.